secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0001628280-23-019588
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept Therapeutics stockholders approve officer exculpation charter amendment at annual meeting
--------------------------------------------------------------------------------

- Stockholders approved amendment to certificate of incorporation to allow officer exculpation under Delaware law.
- All nine management director nominees were elected to serve until 2024 annual meeting.
- Ratified Ernst & Young as independent registered public accounting firm for fiscal year 2023.
- Advisory vote on executive compensation approved; board will hold annual say-on-pay votes through at least 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000162828023019588/0001628280-23-019588-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000162828023019588/cort-20230519.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-019588

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer